Viatim

What is it?

A preparation of inactivated surface antigen and inactivated virus available as a solution in pre-prepared syringes containing 25µg per 0.5ml of purified Vi capsular polysaccharide of Salmonella typhi and 160 antigen units per 0.5ml of inactivated hepatitis A vaccine.

Medical Uses

Immunisation against typhoid fever and hepatitis A.

Dosage

Adults and children aged over 16 years, primary immunisation, 1ml by slow intramuscular injection into deltoid muscle of shoulder. A booster for hepatitis a should be given after 6 to 12 months and a further vaccination for typhoid (with Vi polysaccharide) should be given every 3 years.

Special Care

Pregnancy, breastfeeding.

Avoid Use

Children aged under 16 years, acute feverish illness.

Known Side Effects

Pain/reaction at injection site, headache, malaise, gastrointestinal upset, fever, muscle and joint pain, weakness. Any adverse side effects should be reported to the Committee on the Safety of Medicines (CSM).

Manufacturer

Aventis Pasteur MSD.